JACKSON THORNTON WEALTH MANAGEMENT, LLC
Position in EXEL — Exelixis, Inc.
CIK 1903880
MONTGOMERY, AL
Position in EXEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$312,530
+$30,401 QoQ
Shares Held
5,744
-12.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#510
of 751 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACKSON THORNTON WEALTH MANAGEMENT, LLC holds $2,375,958 across 6 Biotechnology names. EXEL ranks #4 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,638 | $639,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
972 | $606,080 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
791 | $392,912 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
5,744 | $312,530 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
2,502 | $217,548 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
3,631 | $207,765 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,530 | 5,744 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $282,129 | 6,578 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $431,988 | 9,856 | Shares | Other | 2026-01-22 | |
| 2025-09-30 | $316,233 | 7,657 | Shares | Other | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||